FDA arthritis advisory committee meeting: serious gastrointestinal toxicity of nonsteroidal antiinflammatory drugs; drug-containing renal and biliary stones; diclofenac and carprofen approved

FDA arthritis advisory committee meeting

FDA arthritis advisory committee meeting: risks of agranulocytosis/aplastic anemia, flank pain, and adverse gastrointestinal effects with the use of nonsteroidal antiinflammatory drugs

✍ Harold E. Paulus 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 1 views

Agranulocytosislaplastic anemia with the use of nonsteroidal antiinflammatory drugs. A discussion of this subject was prompted by the recently published report of the International Agranulocytosis and Aplastic Anemia (IAAA) Study Group on the risks of those events in relation to use of analgesics (1